Sponsors Seek One-Trial Approval Of Antibiotics For Drug-Resistant Bugs

Antibiotic developers are urging FDA to approve medicines to treat drug-resistant microbes on the basis of a single trial, with other supportive clinical and preclinical data to be used as substantiating evidence.